Home > Healthcare > Medical Devices > Diagnostic Devices > Dual-energy X-ray Absorptiometry (DEXA) Market
Dual-Energy X-Ray Absorptiometry (DEXA) market size was valued at USD 563.2 million in 2022 and is estimated to account for USD 1,219.7 million by 2032. Dual-energy x-ray absorptiometry (DEXA) is a medical imaging technique used to measure and analyze the density of bone and body composition. This system is used to assess bone health, especially for diagnosing osteoporosis and monitoring changes in bone density over time.
DEXA scans work by directing two separate X-ray beams as each beam have different energy levels through the body. One beam is absorbed by soft tissues and the other by bone. The amount of each X-ray beam that is absorbed allows for the calculation of bone mineral density (BMD) and other body composition measurements. The DEXA market is witnessing substantial progression opportunities owing to the increasing prevalence of osteoporosis, rising demand for advanced medical imaging services for early disease diagnosis, and advancements in medical technology. These devices offer several advantages such as in early disease diagnosis, decreased risk of radiation exposure, and improved treatment outcomes.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Dual-energy X-ray Absorptiometry (DEXA) Market Size in 2022: | USD 563.2 Million |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 8% |
2032 Value Projection: | USD 1,219.7 Million |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 231 |
Tables, Charts & Figures: | 409 |
Segments covered: | Technology, Type, Application, End-use and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Advancements in densitometry technology will enhance the development of more sophisticated and precise devices. Advanced DEXA devices offer enhanced precision and accuracy in the diagnosis of osteoporosis as well as monitoring bone density changes over time period. Moreover, modern DEXA systems incorporate lower-dose radiation technology to minimize radiation exposure to patients while maintaining image quality. This will expand patient preference and enhance the adoption rate over the analysis timeframe. Integration of advanced software solutions into DEXA systems to provide better comprehensive analysis further stimulates market expansion. These software offers several additional parameters such as body composition, body fat measurement, and lean mass. This expanded functionality to increase the utility of DEXA in various healthcare settings including sports medicine, nutrition assessment, and obesity management.